William Turner
About William Turner
William Turner serves as the VP and Head of Quantitative & Decision Sciences at Adaptimmune, where he leads enterprise data and analytics strategies focused on T-cell therapies. He has extensive experience in pharmaceutical drug development and clinical research, having held various leadership positions in notable organizations such as ICON plc and AstraZeneca.
Current Role at Adaptimmune
William Turner serves as the Vice President and Head of Quantitative & Decision Sciences at Adaptimmune. In this role, he leads enterprise data and analytics strategies, with a particular focus on T-cell therapies. His leadership is instrumental in translating strategic objectives into actionable plans that drive the organization forward. Turner has been with Adaptimmune since 2022, contributing to the company's mission in the biopharmaceutical sector.
Professional Background
William Turner has extensive experience in the pharmaceutical and clinical research industries. He worked at ICON plc in various capacities, including Associate Director of Statistical Programming from 2008 to 2010 and Senior Director and Global Head of Data Management and SAS Programming from 2010 to 2013. Following his tenure at ICON, he served as VP and Global Head of Programming at AstraZeneca from 2013 to 2019. Turner also held the position of Managing Partner & Principal Consultant at Fortnum Group LLC from 2020 to 2022.
Education and Expertise
William Turner earned a Bachelor of Arts in Economic Theory from American University. His educational background supports his strong expertise in quantitative analysis and decision sciences, which he applies in his current and previous roles within the pharmaceutical industry. His academic foundation complements his practical experience in leading teams and developing enterprise solutions.
Leadership and Recognition
William Turner is recognized for his ability to translate strategy into action and lead teams towards enterprise solutions. He is known for his collaborative approach and relationship-driven engagement in leadership roles. His passion for solving complex challenges extends to developing both individuals and organizations, making him a valued leader in his field.
Board Membership at Nvolve Inc.
In addition to his role at Adaptimmune, William Turner has served as a Board Member at Nvolve Inc. since 2020. His involvement with Nvolve reflects his commitment to contributing to organizational growth and development, leveraging his extensive experience in data analytics and decision sciences.